REGISTER FOR AMCP NEXUS 2020 VIRTUAL Secure the early-bird registration rate by Oct. 1. Register Now Close

Most Popular

What is Managed Care Pharmacy?

AMCP webinar that gave a general overview of managed care pharmacy.

9/22/20

Drug Utilization Review

Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met.

7/18/19

Medication Errors

Medication errors are among the most common medical errors, harming at least 1.5 million people every year. The extra medical costs of treating drug-related injuries occurring in hospitals alone are at least to $3.5 billion a year, and this estimate does not take into account lost wages and productivity or additional health care costs.

7/18/19

Maximum Allowable Cost (MAC) Pricing

Where We Stand: AMCP supports the use of MAC pricing as a managed care tool to encourage the dispensing of cost saving generic drugs and thereby benefiting the overall health care system.

5/20/19

COVID-19 Top Headlines

A curated listing of the top COVID-19 headlines from news organizations and industry publications.

9/29/20

COVID-19 Resources for Managed Care Pharmacy

During the COVID-19 crisis, managed care professionals are facing unique challenges to deliver patient care. This resource center is designed to aggregate timely information for AMCP members and stakeholders.

9/29/20

AMCP Format for Formulary Submissions – Guidance on Submission of...

AMCP Format 4.1 includes new sections describing the evidence needs of HCDMs for unapproved products nearing the end of the product development pipeline, as well as unapproved uses of existing products for which FDA approval is being sought.

4/20/20

Disease Management

Disease management is the concept of reducing health care costs and improving quality of life for individuals with chronic conditions by preventing or minimizing the effects of the disease through integrated care. Disease management programs are designed to improve the health of persons with chronic conditions and reduce associated costs from avoidable complications by identifying and treating chronic conditions more quickly and more effectively, thus slowing the progression of those diseases.

7/18/19

AMCP Summary of FDA Final Rule on Prescription Drug Importation

On September 25, FDA issued a final rule related to the importation of prescription drugs from Canada.

9/29/20

Understanding hATTR Amyloidosis: Clinical Presentation, Patient J...

Sponsored webinar that provided an overview of the ATTR amyloidosis disease subtypes, pathophysiology of disease, and the varying clinical presentations, including nonspecific symptoms that should raise suspicion of and aid in diagnosis of the disease.

9/17/20